Andere talen CANARIABIO Inc.

Aandelen

A016790

KR7016790008

slotkoers Korea S.E. Andere beurzen 00:00:00 29-02-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
994 ^KRW	+8,52%		-.--%	-80,70%

2023	Specialised Therapeutics Asia Pte Ltd tekent exclusieve licentieovereenkomst met CanariaBio voor nieuwe therapie tegen eierstokkanker	CI
2023	CanariaBio Inc. kondigt de voltooiing aan van de registratie van een Fase 2-studie met Oregovomab in combinatie met niraparib voor de behandeling van terugkerende eierstokkanker	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

CANARIABIO Inc.(KOSDAQ:A016790) dropped from S&P Global BMI Index	29/03
Quest PharmaTech Inc. Says Oregovomab Phase III Clinical Study Fails Futility Analysis	24/01
CANARIABIO Inc. announced that it has received KRW 4.999995308 billion in funding from CANARIABIO M Inc.	28/12
CANARIABIO Inc. announced that it expects to receive KRW 4.999995308 billion in funding from CANARIABIO M Inc.	20/12
Specialised Therapeutics Asia Pte Ltd Signs Exclusive License Agreement with CanariaBio for New Ovarian Cancer Therapy	12-10-23
Hikma and CanariaBio sign exclusive licensing agreement to bring Oregovomab to the Middle East and North Africa	11-10-23
CanariaBio Inc. Announces Enrollment Completion of Phase 2 Study of Oregovomab in Combination with Niraparib in the Treatment of Recurrent Ovarian Cancer	08-08-23
CANARIABIO Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	29-03-23
An Unknown buyer agreed to acquire 2.133768% stake in CANARIABIO Inc. from CANARIABIO M Inc. for KRW 14 billion.	14-02-23
CANARIABIO Inc. announced that it has received KRW 15 billion in funding from AT semicon Co., Ltd.	16-01-23
CANARIABIO Inc. announced that it has received KRW 10 billion in funding from AT semicon Co., Ltd.	13-01-23
CANARIABIO Inc. announced that it has received KRW 10 billion in funding from CANARIABIO Inc.	28-12-22
CANARIABIO Inc. announced that it has received KRW 30 billion in funding from CANARIABIO M Inc.	19-12-22
CANARIABIO Inc. announced that it has received KRW 20 billion in funding from CANARIABIO M Inc.	17-11-22
CANARIABIO Inc. announced that it expects to receive KRW 20 billion in funding from CANARIABIO M Inc.	15-11-22
CANARIABIO Inc. announced that it expects to receive KRW 30 billion in funding from CANARIABIO M Inc.	15-11-22
CANARIABIO Inc. announced that it has received KRW 80 billion in funding from CANARIABIO M Inc.	12-10-22
CANARIABIO Inc. announced that it has received KRW 29.999997555 billion in funding from Sejong Medical Co., Ltd.	12-10-22
CANARIABIO Inc. announced that it expects to receive KRW 19.99999837 billion in funding from Sejong Medical Co., Ltd.	04-10-22
CANARIABIO Inc.(KOSDAQ:A016790) added to S&P Global BMI Index	19-09-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen CANARIABIO Inc.

Aandelen

A016790

KR7016790008

Andere talen

Filters